BD Announces Investor Day for December 10, 2026
Becton, Dickinson and Company (BD) will host an Investor Day on December 10, 2026, in New York to discuss its business strategy, capital deployment, and long-term outlook.
Stocks · News reference
FDA 510(k) Clearance for BD OneFlow Diagnostic Tests
Waters Corporation announced that the BD OneFlow LST and B-CLPD T1 tests have received U.S. FDA 510(k) clearance for identifying B-cell non-Hodgkin lymphoma.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Barclays Maintains Underweight on Becton Dickinson, Raises Price Target to $195
RBC Capital Maintains Sector Perform on Becton Dickinson, Raises Price Target to $225
RBC Raises Price Target on Becton, Dickinson and Company
RBC has raised its price target for Becton, Dickinson and Company to $225 from $190 while maintaining a Sector Perform rating.
Piper Sandler Adjusts Price Target on Becton, Dickinson and Company
Piper Sandler has increased its price target for Becton, Dickinson and Company to $200 from $175.
Evercore ISI Group Maintains Outperform on Becton Dickinson, Raises Price Target to $230